메뉴 건너뛰기




Volumn 18, Issue 5, 2008, Pages 1617-1622

4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part I: Synthesis and pharmacological evaluation

Author keywords

4,4 Dimethyl 1,2,3,4 tetrahydroquinoline; Diabetes type 2; PPAR agonists

Indexed keywords

4,4 DIMETHYL 1,2,3,4 TETRAHYDROQUINOLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TESAGLITAZAR; UNCLASSIFIED DRUG;

EID: 39849086207     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.01.067     Document Type: Article
Times cited : (40)

References (28)
  • 13
    • 85120105935 scopus 로고    scopus 로고
    • Parmenon, C.; Viaud-Massuard, M. C.; Guillard, J.; Dacquet, C.; Ktorza, A.; Caignard, D. H. WO2006/079719, 2006.
  • 27
    • 85120116193 scopus 로고    scopus 로고
    • Fused-silica capillary column, 70 cm × 50 μm, applied voltage, −15 kV, buffer 100 mM of phosphoric acid (EtOH) 3 N, pH 3.0, 5 mM. β-Cyclodextrin SBE and 15 mM. β-Cyclodextrin trimethyl, detection at 214 nm, temperature 25 °C, concentration 200 ppm.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.